Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
New Global Research From Allergan Shows New Attitude To Beauty As Women Seek Confidence Over Youth 2016-06-28 19:00
Multinational ADOPT Study Seeks Further Improvement in Management of Oral Mucositis 2016-06-28 15:55
Hetero Launches Biosimilar 'Bevacizumab' for the Treatment of Metastatic Colorectal Cancer (mCRC) Under the Brand Name 'CizumabTM' 2016-06-27 23:41
Life Science Disruptive Technologies and Emerging Trends Spur Growth Opportunities throughout the Industry 2016-06-23 21:35
IriSys Opens Business Development Office in Shanghai 2016-06-22 11:35
Terumo BCT Announces a $17.4 Million Funding Contract from the Biomedical Advanced Research and Development Authority (BARDA) 2016-06-22 03:48
Scarcity of Mass Production Infrastructure Threatens Growth Opportunities in Cell-based Therapies 2016-06-21 21:35
FDA Approves PaxVax to Manufacture Vaxchora™ (Oral Cholera Vaccine) at SynCo Bio Partners 2016-06-20 15:00
Emerging Technologies Driving Disruption and Transformation in Health and Wellness 2016-06-15 21:35
Mundipharma's Raman Singh Listed among Top Five in Global Power List Following a Blockbuster Year 2016-06-15 10:56
Novogen Patent Covering Anisina(TM) Has Proceeded to Grant 2016-06-14 08:30
Victoza® significantly reduced the risk of major cardiovascular events and death in adults with type 2 diabetes in the LEADER trial 2016-06-14 05:15
Semaglutide Demonstrated Superior Improvements in Glycaemic Control vs Sitagliptin (SUSTAIN 2) and Exenatide ER (SUSTAIN 3) in Two Clinical Trials in Adults With Type 2 Diabetes 2016-06-12 22:15
EXAMINE Trial Post-Hoc Analyses of Mortality Data Regarding Cardiovascular Safety of Alogliptin Presented at American Diabetes Association's 76th Scientific Sessions and Published in Diabetes Care 2016-06-12 11:10
ViiV Healthcare Announces FDA Approval to Lower the Weight Limit for dolutegravir in Children and Adolescents Living With HIV 2016-06-10 21:44
ProPak Asia 2016 -- Connecting the World to AEC in Thailand 2016-06-10 15:40
Baricitinib significantly reduces joint damage progression in rheumatoid arthritis in patients who do not respond to conventional DMARDs 2016-06-09 18:45
Patient-reported Outcomes across Phase 3 studies of Baricitinib demonstrate Statistically Significant Improvements in Physical Function and Quality of Life Symptoms in Patients with Rheumatoid Arthritis (RA) 2016-06-09 18:45
Takeda Licenses Global Rights to Theravance Biopharma's TD-8954, a Novel 5-HT4 Agonist and Motility Agent for Gastrointestinal Motility Disorders 2016-06-08 21:02
Disruptive Technologies and Emerging Trends Drive Life Science Transformation 2016-06-07 21:05
1 387 388 389 390 391 412